Neuropathologic characterization of INF2-related Charcot-Marie-Tooth disease: Evidence for a Schwann cell actinopathy

Journal of Neuropathology and Experimental Neurology

Volumn 73, Issue 3, 2014, Pages 223-233

  Mathis, Stéphane ^a,b   Funalot, Benoît ^b,c   Boyer, Olivia ^d,e   Lacroix, Catherine ^f   Marcorelles, Pascale ^g   Magy, Laurent ^b,c   Richard, Laurence ^b,c   Antignac, Corinne ^e,h   Vallat, Jean Michel ^b,c  

^a UNIVERSITÉ DE POITIERS   (France)

^b University of Limoges   (France)

^c LIMOGES UNIVERSITY HOSPITAL   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f BICÊTRE HOSPITAL   (France)

^g BREST UNIVERSITY HOSPITAL   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINS; ADOLESCENT; ADULT; AGED; CHARCOT-MARIE-TOOTH DISEASE; CHILD; CYTOSKELETON; FEMALE; HUMANS; MALE; MICROFILAMENT PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MUTATION; NEURAL CONDUCTION; PERIPHERAL NERVES; PHENOTYPE; SCHWANN CELLS; YOUNG ADULT;

EID: 84894490076     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000047     Document Type: Article

References (52)

1. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997;62:310-18
2. Saporta AS, Sottile SL, Miller LJ, et al. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011;69:22-33
3. Pareyson D, Scaioli V, Laura M. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med 2006;8:3-22
4. Shy ME. Charcot-Marie-Tooth disease: An update. Curr Opin Neurol 2004;17:579-85
5. Lemieux G, Neemeh JA. Charcot-Marie-Tooth disease and nephritis. Can Med Assoc J 1967;97:1193-98
6. Boyer O, Nevo F, Plaisier E, et al. INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy. N Engl J Med 2011;365:2377-88
7. Chhabra ES, Ramabhadran V, Gerber SA, et al. INF2 is an endoplasmic reticulum-associated formin protein. J Cell Sci 2009;122:1430-40
8. Brown EJ, Schlondorff JS, Becker DJ, et al. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat Genet 2010; 42:72-76
9. Boyer O, Benoit G, Gribouval O, et al. Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis. J Am Soc Nephrol 2011;22:239-45
10. Kimura J. Nerve conduction studies and needle electromyography. In: Dyck P, Thomas P eds. Peripheral neuropathy. Philadelphia: Elsevier Saunders, 2005:899-970
11. Wade RH. On and around microtubules: An overview. Mol Biotechnol 2009;43:177-91
12. Vallat JM, Ouvrier RA, Pollard JD, et al. Histopathological findings in hereditary motor and sensory neuropathy of axonal type with onset in early childhood associated with mitofusin 2 mutations. J Neuropathol Exp Neurol 2008;67:1097-102
13. Keita M, Magy L, Heape A, et al. Immunocytological studies of L-MAG expression regulation during myelination of embryonic brain cell cocultures. Dev Neurosci 2002;24:495-503
14. Gaillard J, Ramabhadran V, Neumanne E, et al. Differential interactions of the formins INF2, mDia1, and mDia2 with microtubules. Mol Biol Cell 2011;22:4575-87
15. Korobova F, Ramabhadran V, Higgs HN. An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2. Science 2013;339:464-67
16. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980;103:259-80
17. Madrid R, Bradley WG, Davis CJ. The peroneal muscular atrophy syndrome. Clinical, genetic, electrophysiological and nerve biopsy studies. Part 2. Observations on pathological changes in sural nerve biopsies. J Neurol Sci 1977;32:91-122
18. Bouche P, Gherardi R, Cathala HP, et al. Peroneal muscular atrophy. Part 1. Clinical and electrophysiological study. J Neurol Sci 1983;61:389-99
19. Nicholson G, Myers S. Intermediate forms of Charcot-Marie-Tooth neuropathy: A review. Neuromolecular Med 2006;8:123-30
20. Malandrini A, Ceuterick C, Villanov M, et al. Ultrastructural findings in the peripheral nerve in a family with the intermediate form of Charcot- Marie-Tooth disease. J Submicrosc Cytol Pathol 2001;33:59-63
21. Claeys KG, Zuchner S, Kennerson M, et al. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Brain 2009; 132:1741-52
22. Senderek J, Bergmann C, Ramaekers VT, et al. Mutations in the gangliosideinduced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy. Brain 2003; 126:642-49
23. Schro?der JM. Neuropathology of Charcot-Marie-Tooth and related disorders. Neuromolecular Med 2006;8:23-42
24. Vallat JM, Vital A, Magy L, et al. An update on nerve biopsy. J Neuropathol Exp Neurol 2009;68:833-44
25. Pruyne D, Evangelista M, Yang C, et al. Role of formins in actin assembly: Nucleation and barbed-end association. Science 2002;297: 612-15
26. Andres-Delgado L, Anton OM, Madrid R, et al. Formin INF2 regulates MAL-mediated transport of Lck to the plasma membrane of human T lymphocytes. Blood 2010;116:5919-29
27. Paul AS, Pollard TD. Review of the mechanism of processive actin filament elongation by formins. Cell Motil Cytoskeleton 2009;66:606-17
28. Mattila PK, Lappalainen P. Filopodia: Molecular architecture and cellular functions. Nat Rev Mol Cell Biol 2008;9:446-54
29. Mellor H. The role of formins in filopodia formation. Biochim Biophys Acta 2010;1803:191-200
30. Sun H, Schlondorff JS, Brown EJ, et al. Rho activation of mDia formins is modulated by an interaction with inverted formin 2 (INF2). Proc Natl Acad Sci US A 2011;108:2933-38
31. Madrid R, Aranda JF, Rodriguez-Fraticelli AE, et al. The formin INF2 regulates basolateral-to-apical transcytosis and lumen formation in association with Cdc42 and MAL2. Developmental cell 2010;18:814-27
32. Yang C, Czech L, Gerboth S, et al. Novel roles of formin mDia2 in lamellipodia and filopodia formation in motile cells. PLoS Biol 2007; 5:e317
33. Gabreels-Festen A, van Beersum S, Eshuis L, et al. Study on the gene and phenotypic characterisation of autosomal recessive demyelinating motor and sensory neuropathy (Charcot-Marie-Tooth disease) with a gene locus on chromosome 5q23-q33. J Neurol Neurosurg Psychiatry 1999; 66:569-74
34. Gooding R, Colomer J, King R, et al. A novel Gypsy founder mutation, p.Arg1109X in the CMT4C gene, causes variable peripheral neuropathy phenotypes. J Med Genet 2005;42:e69
35. Houlden H, Laura M, Ginsberg L, et al. The phenotype of Charcot- Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy. Neuromuscul Disord 2009; 19:264-69
36. Senderek J, Bergmann C, Stendel C, et al. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot- Marie-Tooth type 4C neuropathy. Am J Hum Genet 2003;73:1106-19
37. Weis J, Brandner S, Lammens M, et al. Processing of nerve biopsies: A practical guide for neuropathologists. Clin Neuropathol 2012;31:7-23
38. Vallat JM, Tazir M, Magdelaine C, et al. Autosomal-recessive Charcot- Marie-Tooth diseases. J Neuropathol Exp Neurol 2005;64:363-70
39. Arnaud E, Zenker J, de Preux Charles AS, et al. SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system. Proc Natl Acad Sci US A 2009;106:17528-33
40. Stendel C, Roos A, Kleine H, et al. SH3TC2, a protein mutant in Charcot-Marie-Tooth neuropathy, links peripheral nerve myelination to endosomal recycling. Brain 2010;133:2462-74
41. Chhabra ES, Higgs HN. INF2 Is a WASP homology 2 motif-containing formin that severs actin filaments and accelerates both polymerization and depolymerization. J Biol Chem 2006;281:26754-67
42. Sun H, Schlondorff J, Higgs HN, et al. Inverted Formin 2 Regulates Actin Dynamics by Antagonizing Rho/Diaphanous-related Formin Signaling. J Am Soc Nephrol 2013;24:917-29
43. Fernandez-Valle C, Gorman D, Gomez AM, et al. Actin plays a role in both changes in cell shape and gene-expression associated with Schwann cell myelination. J Neurosci 1997;17:241-50
44. Feltri ML, Suter U, Relvas JB. The function of RhoGTPases in axon ensheathment and myelination. Glia 2008;56:1508-17
45. Sparrow N, Manetti ME, Bott M, et al. The actin-severing protein cofilin is downstream of neuregulin signaling and is essential for Schwann cell myelination. J Neurosci 2012;32:5284-97
46. Webster HD. The geometry of peripheral myelin sheaths during their formation and growth in rat sciatic nerves. J Cell Biol 1971;48:348-67
47. Wang H, Tewari A, Einheber S, et al. Myosin II has distinct functions in PNS and CNS myelin sheath formation. J Cell Biol 2008;182:1171-84
48. Jin F, Dong B, GeorgiouJ, et al. N-WASp is required for Schwann cell cytoskeletal dynamics, normal myelin gene expression and peripheral nerve myelination. Development 2011;138:1329-37
49. Chan JR, Jolicoeur C, Yamauchi J, et al. The polarity protein Par-3 directly interacts with p75NTR to regulate myelination. Science 2006; 314:832-36
50. Etienne-Manneville S. Polarity proteins in glial cell functions. Curr Opin Neurobiol 2008;18:488-94
51. Ozcelik M, Cotter L, Jacob C, et al. Pals1 is a major regulator of the epithelial-like polarization and the extension of the myelin sheath in peripheral nerves. J Neurosci 2010;30:4120-31
52. Calvo J, Funalot B, Ouvrier RA, et al. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations. Arch Neurol 2009;66:1511-16